BROWN, Matthew Frank,DERMENCI, Alpay,FENSOME, Andrew,GERSTENBERGER, Brian Stephen,HAYWARD, Matthew Merrill,OWEN, Dafydd Rhys,WRIGHT, Stephen Wayne,XING, Li Huang,YANG, Xiaojing
申请号：
HUE17705705
公开号：
HUE049305T2
申请日:
2017.02.10
申请国别(地区):
HU
年份:
2020
代理人:
摘要：
A compound having the structure:or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable solvate of said compound or pharmaceutically acceptable salt, wherein A, A', A", R<；sub>；0<；/sub>；, R, R<；sub>；1<；/sub>；, R<；sub>；2<；/sub>；, X, R<；sub>；4<；/sub>；, and R<；sub>；5<；/sub>；, are as defined in the description, for therapeutic use, wherein where the compound, or the pharmaceutically acceptable salt thereof, or the pharmaceutically acceptable solvate of said compound or pharmaceutically acceptable salt, is administered orally.
